Candida auris for the clinical microbiology laboratory: Not your grandfather's Candida species

Clinical Microbiology Newsletter
Shawn R LockhartRory M Welsh

Abstract

Candida auris is a newly emerging species that was first identified in Asia in 2009 but has rapidly spread across the world. C. auris differs from most other Candida species in that antifungal resistance is the norm rather than the exception, it is a commensal of human skin rather than the human gut, and it can be easily transmitted from person to person in a healthcare setting. This review discusses the emergence of C. auris, global epidemiology, identification, antifungal susceptibility testing, and precautions to be taken when it is identified from a patient specimen.

Citations

Nov 22, 2017·Antimicrobial Agents and Chemotherapy·Ruvini U PathiranaMira Edgerton
Apr 11, 2018·Antimicrobial Agents and Chemotherapy·Milena KordalewskaDavid S Perlin
Nov 17, 2017·Clinical Microbiology Reviews·Anna Jeffery-SmithColin S Brown
Jun 8, 2018·Current Opinion in Infectious Diseases·Katja SarisAndreas Voss
Aug 8, 2018·Antimicrobial Agents and Chemotherapy·Kelley R HealeyDavid S Perlin
Sep 21, 2018·Journal of Clinical Microbiology·D Joseph SextonAnastasia P Litvintseva
Dec 6, 2018·Acta Clinica Belgica·Klaas DewaeleKatrien Lagrou
Jun 7, 2019·Archives of Pathology & Laboratory Medicine·D Jane HataCollege of American Pathologists Microbiology Committee
Jun 4, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Giann Carlos Peñaloza AtuestaJonh Jairo Méndez Arteaga
Apr 20, 2019·Frontiers in Cellular and Infection Microbiology·Haroldo Cesar de OliveiraOscar Zaragoza
Sep 11, 2019·Protein Science : a Publication of the Protein Society·Elizabeth MisasOliver K Clay
Mar 30, 2018·Emerging Microbes & Infections·Johanna RhodesSilke Schelenz
Aug 20, 2019·Internal Medicine Journal·Chong W OngAustralian and New Zealand Mycoses Interest Group (ANZMIG); and the Healthcare Infection Control Special Interest Group (HIC
Aug 8, 2018·Medical Mycology·Kaitlin ForsbergSnigdha Vallabhaneni
Nov 7, 2018·Journal of Intensive Care·Andrea CortegianiAnuradha Chowdhary
Aug 23, 2019·Journal of Fungi·Milena Kordalewska, David S Perlin
May 23, 2020·Infection and Drug Resistance·Muluneh Ademe, Friehiwot Girma
May 1, 2020·Frontiers in Genetics·Aleksandra D ChybowskaRhys A Farrer
Sep 5, 2019·Frontiers in Microbiology·Milena Kordalewska, David S Perlin
Oct 14, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E Elcocks, E C Adukwu
Nov 17, 2020·Frontiers in Microbiology·Elizabeth MisasOliver K Clay
Nov 20, 2020·Journal of Clinical Microbiology·Sourav DasAnup Ghosh
Nov 13, 2020·Current Clinical Microbiology Reports·Mark V Horton, Jeniel E Nett
Mar 7, 2021·Journal of Fungi·Katie Lynn SummersAnn M Arfken
Mar 10, 2019·Biochimica Et Biophysica Acta. Proteins and Proteomics·Brian C MonkMikhail V Keniya
May 18, 2021·Enfermedades Infecciosas Y Microbiologia Clinica·Juan Vicente Mulet-BayonaConcepción Gimeno-Cardona

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved